Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “New York”

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)Recruiting
NCT06430801Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Crohn's Disease
United States, Australia, Austria, Belgium, Brazil +42 more
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)Recruiting
NCT06077760Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Argentina, Australia, Belgium, Brazil +28 more
Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal CancerActive Not Recruiting
NCT01893307Phase 3Updated Aug 21, 2026
Sponsor: M.D. Anderson Cancer Center
Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 · Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 · Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7
United States
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)Recruiting
NCT07174336Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Breast Neoplasms · Neoplasm Metastasis
United States, Argentina, Australia, Belgium, Brazil +14 more
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLRecruiting
NCT07007312Phase 3Updated Aug 20, 2026
Sponsor: Kura Oncology, Inc.
Acute Myeloid Leukemia (AML)
United States, Australia, Belgium, Canada, Czechia +11 more
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisRecruiting
NCT07184996Phase 3Updated Aug 20, 2026
Sponsor: Sanofi
Ulcerative Colitis
United States, Bulgaria, Canada, China, Czechia +15 more
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck CancerSuspended
NCT01810913Phase 2, Phase 3Updated Aug 20, 2026
Sponsor: National Cancer Institute (NCI)
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma · Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 · Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 · Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
United States, Canada, Hong Kong
A Study to Test Whether Nerandomilast Helps People With Systemic SclerosisRecruiting
NCT07497087Phase 3Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Systemic Sclerosis
United States, Argentina, Australia, Austria, Belgium +40 more
Prophylactic Reinforcement of Ventral Abdominal Incisions TrialActive Not Recruiting
NCT03911700NAUpdated Aug 20, 2026
Sponsor: C. R. Bard
Open Midline Laparotomy
United States, Austria, Belgium, France, Germany
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF TherapyActive Not Recruiting
NCT05889182Phase 3Updated Aug 20, 2026
Sponsor: AbbVie
Hidradenitis Suppurativa
United States, Argentina, Australia, Austria, Belgium +32 more
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube CancerActive Not Recruiting
NCT01081262Phase 3Updated Aug 20, 2026
Sponsor: National Cancer Institute (NCI)
Borderline Ovarian Mucinous Tumor · Ovarian Mucinous Cystadenocarcinoma · Recurrent Fallopian Tube Carcinoma · Recurrent Ovarian Carcinoma
United States
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseRecruiting
NCT07064473Phase 3Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Diabetes Mellitus, Type 2 · Hypertension · Cardiovascular Diseases
United States, Argentina, Australia, Austria, Belgium +46 more
Effects of Stopping Hydroxychloroquine in Elderly Lupus DiseaseRecruiting
NCT05799378Phase 3Updated Aug 20, 2026
Sponsor: NYU Langone Health
Systemic Lupus Erythematosus
United States
Low Gas Pressure vs Standard Gas Pressure in Robotic SurgeryRecruiting
NCT07710352NAUpdated Aug 20, 2026
Sponsor: Weill Medical College of Cornell University
Robotic Surgery · Pneumoperitoneum
United States
A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved IndicationRecruiting
NCT07612267Phase 4Updated Aug 20, 2026
Sponsor: Eli Lilly and Company
Lactation · Inflammatory Bowel Disease
United States, Canada, Denmark, Germany, Israel +2 more
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With NerandomilastRecruiting
NCT06238622Phase 3Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Idiopathic Pulmonary Fibrosis · Progressive Pulmonary Fibrosis
United States, Argentina, Australia, Austria, Belgium +39 more
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular DegenerationRecruiting
NCT07441642Phase 2Updated Aug 20, 2026
Sponsor: Novartis Pharmaceuticals
Geographic Atrophy Secondary to Age-related Macular Degeneration
United States, Australia, Bulgaria, Canada, Czechia +10 more
A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world DatabaseCompleted
NCT06962969N/AUpdated Aug 20, 2026
Sponsor: Pfizer
Advanced or Metastatic Breast Cancer
United States
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)Recruiting
NCT05554406Phase 2Updated Aug 20, 2026
Sponsor: National Cancer Institute (NCI)
Acute Myeloid Leukemia · Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm · Acute Myeloid Leukemia Post Cytotoxic Therapy · Acute Myeloid Leukemia, Myelodysplasia-Related
United States, Canada, Puerto Rico
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their BabiesRecruiting
NCT07160244Phase 3Updated Aug 20, 2026
Sponsor: Pfizer
Healthy
United States, Argentina, Brazil, Canada, Finland +9 more
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease ProgressionNot Yet Recruiting
NCT07540988Phase 3Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Interstitial Lung Diseases
United States, Argentina, Austria, Belgium, Brazil +14 more
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of MigraineRecruiting
NCT07645924Phase 3Updated Aug 20, 2026
Sponsor: Kallyope Inc.
Migraine
United States
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3Recruiting
NCT05614739Phase 1Updated Aug 20, 2026
Sponsor: Eli Lilly and Company
Urinary Bladder Neoplasms · Neoplasm Metastasis · Ureteral Neoplasms
United States, Australia, Canada, China, France +9 more
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With BronchiectasisRecruiting
NCT06872892Phase 3Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Bronchiectasis
United States, Argentina, Australia, Austria, Belgium +40 more
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic DiseasesRecruiting
NCT06806592Phase 3Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Interstitial Lung Diseases · Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
United States, Australia, Austria, China, France +11 more

Previous page Next page